Boston's "smallest" DR (dual chamber) ICD (implantable cardioverter defibrillator):
This article was originally published in Clinica
Executive Summary
Japanese regulators have given Boston Scientific the all-clear to sell what the firm claims is the country's smallest dual chamber (DR) implantable cardioverter defibrillator (ICD). Vitality DR features a size and shape (30cc and 11mm) that is designed to facilitate ease of insertion and contribute to patient comfort, said the company. It also incorporates Boston's AV Search Hysteresis programming, which proactively reduces right ventricular pacing when the heart's natural rhythm is present. Over 100,000 ICDs from the Vitality family have been implanted worldwide since the system was first introduced in Europe in 2002. Each year, sudden cardiac death kills 50,000 people in Japan, said Boston.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.